血清Galectin-3和脑钠肽在心脏再同步化治疗前后的变化及对近期预后的影响  被引量:9

The changes of plasma Galectin-3 and brain natriuretic peptide(BNP) levels and prognostic values in the heart failure patients after cardiac resynchronization therapy

在线阅读下载全文

作  者:李英[1] 赵瑞富[1] 李建平[1] 荆艳艳[1] 杨军[1] 葛培培[1] 张传焕[1] 初红霞[1] 

机构地区:[1]烟台毓璜顶医院心内科,山东烟台264000

出  处:《临床心血管病杂志》2017年第1期30-33,共4页Journal of Clinical Cardiology

基  金:烟台市科技发展计划项目(No:2013WS223)

摘  要:目的:分析我院行心脏再同步化治疗(CRT)前后心力衰竭(心衰)患者血清半乳糖凝集素3(Gal-3)、脑钠肽(BNP)水平变化及其对近期预后的影响。方法:对本院50例心衰患者的随访资料进行分析,随访时间12个月,根据患者是否接受CRT治疗分为CRT组及对照组,采用酶联免疫法(ELISA)检测治疗前及治疗后1、3、6、12个月血清Gal-3和BNP水平,并行超声心动图检查,评估心脏功能。结果:随访至12个月,CRT组和对照组Gal-3水平无明显变化,两组BNP水平均显著下降,且CRT组显著低于对照组(P<0.05);CRT组左室舒张末容积(LVEDV)、左室收缩末容积(LVESV)均减小(P<0.05),左室射血分数(LVEF)明显升高(P<0.05);CRT组患者心衰再入院率显著低于对照组(分别为20%、52%,P=0.019),发生心脏不良事件再入院者基础Gal-3和BNP水平更高。结论:血清Gal-3在心衰患者治疗前后无明显变化,基础Gal-3和BNP水平高者近期预后较差。Objective:To investigate the alterations of serum Galectin-3(Gal-3 )and brain natriuretic peptide(BNP),and its values for predicting cardiovascular outcomes with the effect of cardiac resynchronization therapy(CRT)on the patients with heart failure.Method:A retrospective review on Fifty patients with heart failure was conducted.Patients were divided into CRT group and control group.Plasma levels of Gal-3 and BNP were detected before CRT,1,3,6 and 12 months after CRT.Result:The levels of Gal-3 did not change throughout the 12-month follow-up period.Plasma level of BNP was significantly reduced,and CRT group decreased significantly compared with control group(P〈0.05).The left ventricular end-diastolic volume(LVEDV)and left ventricular end-systolic volume(LVESV)were decreased,while left ventricular ejection fraction(LVEF)was significantly increased in CRT group followed up to 12 months(P〈0.05).CRT group was associated with lower adverse cardiac events compared with control group(20% vs 52%,P=0.019).Patients with higher levels of Gal-3 and BNP were associated with a higher risk of adverse cardiac events.Conclusion:Gal-3 levels exhibited no significant change over the 12-month follow-up period.Patients with higher levels of both baseline Gal-3 and BNP were significantly more likely to be rehospitalized.

关 键 词:心脏再同步化治疗 半乳糖凝集素3 脑钠肽 

分 类 号:R541.6[医药卫生—心血管疾病]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象